The Journal of Addictions Nursing, published by Lippincott Williams & Wilkins, serves as a pivotal resource in the field of psychiatric and mental health nursing. With an ISSN of 1088-4602 and an E-ISSN of 1548-7148, this esteemed journal has been dedicated to advancing the knowledge and practice of addiction nursing since its inception in 1989. As of 2023, it ranks in the Q3 category of psychiatry and mental health, highlighting its significance amidst its peers. The journal provides a platform for the dissemination of original research, reviews, and clinical practices that address the complexities of addiction treatment and care. While it currently does not offer open access options, its valuable insights are accessible to practitioners and researchers committed to improving patient outcomes. With content spanning from 1989 to 2024, the journal continues to shape the discourse in this vital area of nursing, making it an essential read for professionals and scholars aiming to stay at the forefront of addiction nursing and intervention strategies.

Welcome to the Harm Reduction Journal, a premier academic platform published by BMC, dedicated to advancing the field of harm reduction since its inception in 2004. With an impressive track record as an Open Access publication, this journal addresses critical topics within the broad scope of medicine, psychiatry, and public health, making it indispensable for researchers, healthcare professionals, and students alike. As of 2023, it proudly holds a Q1 ranking in prestigious categories including Medicine (Miscellaneous), Psychiatry and Mental Health, and Public Health, Environmental and Occupational Health, reflecting its high impact and significance in the academic community. The journal is notable for its comprehensive discussions on innovative harm reduction strategies, public policy considerations, and evidence-based practice, fostering collaboration and knowledge exchange. With a global reach and commitment to enhancing health outcomes, the Harm Reduction Journal serves as a vital resource in the ever-evolving landscape of public health and addiction research.

Substance Abuse Treatment, Prevention, and Policy is a premier open access journal published by BMC, dedicated to advancing the understanding and improvement of substance abuse treatment and prevention strategies. Since its inception in 2006, this journal has established itself as a significant resource in the fields of Health Policy and Psychiatry and Mental Health, proudly maintaining a strong reputation reflected in its 2023 Scopus rankings, which place it in the top quartiles of these categories. With an impactful focus on policy implications and evidence-based practices, the journal's comprehensive coverage supports the sharing of innovative research and perspectives aimed at mitigating substance abuse challenges worldwide. Open access since its launch, it ensures that vital research is readily available to researchers, practitioners, and students alike, facilitating collaboration and discourse in this critical area of public health. Its commitment to high-quality research is underscored by its rankings within the 78th percentile for Health Policy and 66th percentile for Psychiatry and Mental Health, highlighting its influence and relevance in addressing pressing issues in substance misuse.

Welcome to the Journal of Addiction Medicine, a premier academic resource devoted to the field of addiction studies, published by LIPPINCOTT WILLIAMS & WILKINS. Since its inception in 2007, this esteemed journal has become a leader in disseminating groundbreaking research, with impressive rankings in the Q1 quartile across key disciplines such as Medicine (Miscellaneous), Pharmacology (Medical), and Psychiatry and Mental Health, reflecting its significance in the scholarly community. With an ISSN of 1932-0620 and an E-ISSN of 1935-3227, it caters to a diverse audience of researchers, clinicians, and students seeking to expand their understanding of addiction medicine. The journal's articles are primarily published in a non-open access format, ensuring high-quality research is accessible through institutional subscriptions. With a Scopus ranking that positions it within the top tiers of several relevant categories, the Journal of Addiction Medicine is essential for anyone committed to advancing knowledge in the field and addressing the complexities surrounding addiction.

ADDICTIVE BEHAVIORS is a prestigious journal published by PERGAMON-ELSEVIER SCIENCE LTD, specializing in the critical examination and exploration of addiction-related issues across diverse fields including Clinical Psychology, Psychiatry and Mental Health, and Toxicology. With a robust history dating back to 1975 and convergence extending to 2024, the journal is esteemed for its rigorous peer-reviewed research that contributes significantly to understanding addiction phenomena. Ranked in the Q1 category for its focus areas, it stands out within the academic community, evidenced by its impressive Scopus rankings—25th in Clinical Psychology and 14th in Toxicology—placing it in the top tier of its disciplines. This journal offers valuable insights into addiction behaviors, treatment methodologies, and public health implications, making it an essential resource for researchers, practitioners, and students seeking to advance their knowledge and impact the field. Although not Open Access, it provides vital access options for institutions and individuals invested in addiction studies.

JOURNAL OF SUBSTANCE ABUSE TREATMENT, published by Pergamon-Elsevier Science Ltd, is a leading peer-reviewed journal that spans a wide range of topics related to substance abuse and addiction treatments. With an impressive impact factor, this esteemed journal ranks in the Q1 quartile across multiple disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, making it a vital resource for researchers and practitioners alike. Covering convergence years from 1984 to 2023, it publishes cutting-edge research that informs treatment methodologies and policy development in the field of substance abuse. With access options that adapt to both traditional and modern academic needs, the journal seeks to advance the understanding and effectiveness of substance abuse treatment through comprehensive studies and innovative approaches. Be part of a global dialogue that shapes the future of addiction treatment by engaging with the latest findings and expert analyses that help bridge the gap between research and clinical practice.

Drug and Alcohol Dependence is a premier journal published by Elsevier Ireland Ltd, dedicated to the rigorous exploration and analysis of substance use disorders, including drug and alcohol dependencies. With its established history since 1975 and a remarkable convergence of research extending to 2024, the journal holds a prestigious position within the academic community, evidenced by its Q1 ranking in multiple categories, including Pharmacology, Psychiatry and Mental Health, and Toxicology for 2023. It ranks impressively among its peers, underscored by Scopus rankings of #46, #99, and #27 in key fields related to medical pharmacology and toxicology. As a non-open access title, it caters to a global readership of researchers, professionals, and students, providing them with peer-reviewed insights into critical developments and innovative methodologies in the field. The journal’s commitment to advancing knowledge and understanding of drug and alcohol dependence is essential for addressing the global challenges posed by substance use, making it a valuable resource for all stakeholders in public health and clinical practice.

ALCOHOL-CLINICAL AND EXPERIMENTAL RESEARCH, published by WILEY, is a leading peer-reviewed journal dedicated to advancing the understanding of alcohol use and its clinical implications. With an impressive impact factor and categorized in the top quartile (Q1) in Medicine (miscellaneous), Psychiatry and Mental Health, and Toxicology, this journal serves a crucial role in disseminating high-quality research that informs clinical practice and health policy. The journal’s scope encompasses a wide range of topics related to alcohol use, including its effects on mental health, addiction, and public health, providing a vital platform for professionals, researchers, and students committed to enhancing knowledge in the field. The journal operates in the United States and is known for its rigorous editorial standards, ensuring that published articles contribute valuable insights to ongoing discussions in medicine and behavioral health. As of 2023-2024, the journal continues to thrive in a competitive academic landscape, aiming to foster collaboration and innovation in alcohol-related research.

Substance Abuse is a premier scholarly journal published by SAGE Publications Inc, dedicated to advancing the understanding and treatment of substance use disorders. With an established presence from 1995 to 2023, the journal boasts an impressive Q1 ranking in both Medicine (miscellaneous) and Psychiatry and Mental Health, positioning it among the top tier of academic publications in these fields. Researchers and professionals will find its articles, which are grounded in rigorous empirical studies and innovative interventions, essential for addressing the complex and multifaceted nature of substance abuse. Although not an open access publication, Substance Abuse maintains a commitment to sharing valuable insights and findings, making it a vital resource for those looking to enhance their knowledge and practice. Located in Thousand Oaks, CA, this journal serves as a critical forum for international dialogue and research dissemination, ensuring that current trends and challenges in substance use are thoughtfully examined and discussed within the academic community.

SUBSTANCE USE & MISUSE, published by Taylor & Francis Inc, is an esteemed academic journal dedicated to the multifaceted study of substance use and its implications on health and society. With a notable impact factor and categorized in the Q2 quartile across multiple fields—including Health (Social Science), Medicine (Miscellaneous), Psychiatry and Mental Health, as well as Public Health—this journal serves as an essential platform for researchers, professionals, and students alike. Spanning from 1966 to 2024, it provides a rich archive of peer-reviewed articles that explore current trends, innovative research, and evidence-based practices in the management and understanding of substance use. The journal offers various access options, catering to the diverse needs of its audience and affirming its commitment to fostering scholarly discourse in the United Kingdom and beyond. By engaging with this journal, readers can enhance their understanding of the complexities surrounding substance use, making it a crucial resource for advancing knowledge and informing policy in this critical area of public health.